ATE402703T1 - Tablette enthaltend efletirizin und pseudoephedrin - Google Patents

Tablette enthaltend efletirizin und pseudoephedrin

Info

Publication number: ATE402703T1
Authority: AT; Austria
Prior art keywords: pseudoephedrine; tablet containing; efletirizine; containing efletirizine; tablet
Prior art date: 2002-12-06

Application number

AT03779899T

Other languages

English (en)

Inventor

Monique Berwaer

Anthony Guichaux

Serge Cuypers

Michel Deleers

Domenico Fanara

Original Assignee

Ucb Farchim Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-06

Filing date

2003-11-12

Publication date

2008-08-15

2003-11-12 Application filed by Ucb Farchim Sa filed Critical Ucb Farchim Sa

2008-08-15 Application granted granted Critical

2008-08-15 Publication of ATE402703T1 publication Critical patent/ATE402703T1/de

Links

BAWMMJAUVBLLEE-UHFFFAOYSA-N 2-[2-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]ethoxy]acetic acid Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 BAWMMJAUVBLLEE-UHFFFAOYSA-N 0.000 title 1
KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 title 1
229950003420 efletirizine Drugs 0.000 title 1
KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 title 1
229960003908 pseudoephedrine Drugs 0.000 title 1
230000000172 allergic effect Effects 0.000 abstract 1
208000010668 atopic eczema Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Virology (AREA)
Pulmonology (AREA)
Emergency Medicine (AREA)
Ophthalmology & Optometry (AREA)
Immunology (AREA)
Oncology (AREA)
Otolaryngology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT03779899T 2002-12-06 2003-11-12 Tablette enthaltend efletirizin und pseudoephedrin ATE402703T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP02080127		2002-12-06

Publications (1)

Publication Number	Publication Date
ATE402703T1 true ATE402703T1 (de)	2008-08-15

Family

ID=32479751

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03779899T ATE402703T1 (de)	2002-12-06	2003-11-12	Tablette enthaltend efletirizin und pseudoephedrin

Country Status (9)

Country	Link
US (2)	US20060122194A1 (de)
EP (1)	EP1569651B1 (de)
JP (1)	JP2006510639A (de)
AT (1)	ATE402703T1 (de)
AU (1)	AU2003288041A1 (de)
CA (1)	CA2507042A1 (de)
DE (1)	DE60322577D1 (de)
MX (1)	MXPA05005326A (de)
WO (1)	WO2004052367A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070185122A1 (en) *	2003-05-28	2007-08-09	Christophe Revirron	Use of efletirizine for treating persistent allergic rhinitis
TWI471145B (zh) *	2005-06-13	2015-02-01	Bristol Myers Squibb & Gilead Sciences Llc	單一式藥學劑量型
WO2009006892A1 (en) *	2007-07-11	2009-01-15	Fertin Pharma A/S	Stable medicated chewing gum comprising antioxidant
EP3646856B1 (de)	2017-06-27	2023-11-22	Daiichi Sankyo Company, Limited	Tablette

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6469009B1 (en) *	1996-04-08	2002-10-22	Ucb, S.A.	Pharmaceutical compositions for the treatment of rhinitis
EP0811374A1 (de) *	1996-05-29	1997-12-10	Pfizer Inc.	Formulierung für ein Kombinationspräparat mit Cetirizin und Pseudoephedrin
CA2277220A1 (en) *	1997-01-10	1998-07-16	Abbott Laboratories	Tablet for the controlled release of active agents
BE1011045A3 (fr) *	1997-03-14	1999-04-06	Ucb Sa	Compositions pharmaceutiques pour la liberation controlee de substances actives.
US5869479A (en) *	1997-08-14	1999-02-09	Schering Corporation	Treatment of upper airway allergic responses
NZ520907A (en) *	1997-12-23	2004-05-28	Schering Corp	Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
US6103735A (en) *	1998-10-09	2000-08-15	Schering Corporation	Composition and method for treating allergic diseases
US6051585A (en) *	1998-12-07	2000-04-18	Weinstein; Robert E.	Single-dose antihistamine/decongestant formulations for treating rhinitis

2003
- 2003-11-12 CA CA002507042A patent/CA2507042A1/en not_active Abandoned
- 2003-11-12 AT AT03779899T patent/ATE402703T1/de not_active IP Right Cessation
- 2003-11-12 US US10/537,553 patent/US20060122194A1/en not_active Abandoned
- 2003-11-12 WO PCT/EP2003/012627 patent/WO2004052367A1/en not_active Ceased
- 2003-11-12 MX MXPA05005326A patent/MXPA05005326A/es active IP Right Grant
- 2003-11-12 DE DE60322577T patent/DE60322577D1/de not_active Expired - Fee Related
- 2003-11-12 JP JP2004557899A patent/JP2006510639A/ja active Pending
- 2003-11-12 EP EP03779899A patent/EP1569651B1/de not_active Expired - Lifetime
- 2003-11-12 AU AU2003288041A patent/AU2003288041A1/en not_active Abandoned
2007
- 2007-06-14 US US11/762,867 patent/US20080206331A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU2003288041A1 (en)	2004-06-30
WO2004052367A1 (en)	2004-06-24
CA2507042A1 (en)	2004-06-24
EP1569651B1 (de)	2008-07-30
US20060122194A1 (en)	2006-06-08
MXPA05005326A (es)	2005-10-10
EP1569651A1 (de)	2005-09-07
US20080206331A1 (en)	2008-08-28
JP2006510639A (ja)	2006-03-30
DE60322577D1 (de)	2008-09-11

Legal Events

Date	Code	Title	Description
2009-01-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE432068T1 (de)	2009-06-15	Cetirizin und pseudoephedrin enthaltende tablette
PT1605956E (pt)	2016-03-09	Administração de capsaicinóides para o tratamento da osteoartrite
EA200501570A1 (ru)	2006-06-30	Новые гидроксаматы как лечебные средства
CY1108932T1 (el)	2014-07-02	Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
HUE040046T2 (hu)	2019-02-28	Gyógyszerészeti készítmények és hatóanyagok beadására szolgáló eljárások
ATE514418T1 (de)	2011-07-15	Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan
CY1109238T1 (el)	2014-07-02	Δισκιο περιεχον σετιριζινη και ψευδοεφεδρινη
DK1546127T3 (da)	2007-12-10	Nye pyrimidinamidderivater og anvendelse deraf
DE60209152D1 (de)	2006-04-20	Pharmazeutische zusammensetzung, umfassend gabapentin oder ein analogon davon und ein alpha-aminoamid
BR0207883A (pt)	2004-07-27	Composições de medicamentos à base de anticolenérgicos e inibidores de pde-iv
EP1781277A4 (de)	2008-09-03	Kombinationspräparat
BRPI0411176A (pt)	2006-07-18	combinação farmacêutica consistindo de modafinil e outra droga
SE0302488D0 (sv)	2003-09-18	New combination
ATE524186T1 (de)	2011-09-15	Pharmazeutische kombinationen bestehend aus meloxicam, tramadol und paracetamol
DE60322577D1 (de)	2008-09-11	Tablette enthaltend efletirizin und pseudoephedrin
DE502004002706D1 (de)	2007-03-08	Darreichungsform zur oralen verabreichung von wirkstoffen, vitaminen und/oder nährstoffen, kit und verwendung
NO20053247L (no)	2005-07-01	Anvendelse av levocetirizin ved behandling av vedvarende allergisk rhinitt.
DE10390700D2 (de)	2005-02-17	Kapsel zur zeitversetzten Verabreichung von Nähr- und/oder Wirkstoffen
DE50304524D1 (de)	2006-09-14	Arzneimittel enthaltend substituierte 2,5-diaminomethyl-1h-pyrrole
ITMI20020055A1 (it)	2003-07-15	Composizione medicinale per il trattamento della degenerazione artilaginea
DOP2003000657A (es)	2004-01-31	Amidas de acidos 2-heteroarilcarboxilicos